Adults – more in number, varied aetiologies, longer waiting lists and develop all complications including HRS
HRS in Paediatrics VERY RARE.
Hepatorenal syndrome (HRS) is defined as the occurrence of renal failure in a patient with advanced liver disease in the absence of an identifiable cause of renal failure
DIAGNOSIS OF EXCLUSION
Bilirubin interferes with assays, with hyperbilirubinaemia masking increase in SCr
Bilirubin interferes with assays, with hyperbilirubinaemia masking increase in SCr
Ethnic and Sex predilection
Liver synthetic function -production of creatinine is reduced by 50%
Muscle mass and protein malnutrition
Lower baseline range for creatinine in advanced liver disease
Cirrhotic patients for a given change in GFR have smaller and delayed changes in SCr
Delay access to timely HRS treatment and may adversely affect these patients’ prognosis.
Nitric Oxide (shear-stress-induced upregulation of endothelial NO synthase (eNOS) activity and endotoxin-mediated eNOS)
Nitric Oxide (shear-stress-induced upregulation of endothelial NO synthase (eNOS) activity and endotoxin-mediated eNOS)
Calcitonin gene-related peptide (CGRP)
Substance P
Carbon monoxide
Endocannabinoids
Overproduction of TNF-α may be a major mechanism leading to HRS
Lead to rapid deterioration of the systemic circulation and to the development of the HRS
Lead to rapid deterioration of the systemic circulation and to the development of the HRS
Gastrointestinal bleeding
Spontaneous bacterial peritonitis
Sepsis
Aggressive diuresis
Large volume Paracentesis
Cholestasis
NSAIDs
Hepatorenal syndrome (HRS) is defined as the occurrence of renal failure in a patient with advanced liver disease in the absence of an identifiable cause of renal failure
The diagnosis of HRS is one of exclusion, so investigations should be performed to rule out other common causes of AKI.
HRS and ATN difficult to differentiate
HRS and ATN difficult to differentiate
Granular casts observed in the urinary sediment in both conditions
Presence of renal tubular epithelial cells favours ATN
Hpovolemic or septic shock immediately before renal failure - ATN
Prolonged HRS ----- ATN ????
Depends on etiology
Depends on etiology
HRS carries the worst survival among all causes of AKI in cirrhotic patients
562 cirrhotic patients with AKI
3-month survival :
HRS patients -15%
Infection induced AKI - 31%
Hypovolemia-induced AKI -46%
AKI associated with evidence of parenchymal renal disease - 73%
Determining the etiology of AKI in cirrhotic patients does not only determine the treatment plan but also foretells the prognosis.
Patients with cirrhosis and renal failure are at high risk for death while awaiting transplantation
Patients with cirrhosis and renal failure are at high risk for death while awaiting transplantation
HRS is a strong predictor of mortality
In patients listed for transplantation, the development of HRS – Untransplantable or who receive a transplant associated with increased morbidity and mortality after transplantation
Initially histological abnormalities are minimal and inconsistent
Initially histological abnormalities are minimal and inconsistent
Tubular function and sodium absorption remains intact
Kidneys transplanted from patients with HRS can resume normal function in the recipient
Renal function can return in patients with HRS who receive liver transplant
Only 2/3rds recover kidney function after transplantation.
Gines et al – 134 HRS patients
Gines et al – 134 HRS patients
2-week mortality rate 80% in untreated type 1 HRS patients with only 10% of patients surviving for 3 months
Salerno et al - 116 HRS patients
Some of them did receive vasoconstrictor therapy
3-month survival was 20% and 40% for type 1 and type 2 HRS, respectively.
AKI common in decompensated cirrhotics
AKI common in decompensated cirrhotics
Not every AKI in cirrhosis is HRS
Extremely rare in paediatrics
AKI predicts increased mortality in liver disease
HRS drastic complication and carries a very bad prognosis
Splanchnic vasodilatation and renal vasoconstriction – main causes